Post Wed Jan 24, 2024 7:06 pm

2024-Mahalingam et al-Commun Med

"First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors"
Devalingam Mahalingam, Wael Harb, Amita Patnaik, Andrea Bullock, Randolph S Watnick, Melanie Y Vincent, Jian Jenny Chen, Suming Wang, Harold Pestana, Judy Chao, James Mahoney, Michael Cieslewicz, Jing Watnick
Commun Med. 2024, 4, 10
https://doi.org/10.1038/s43856-024-00433-x

- no dataset accession given